Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Revenue

In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth. Foghorn Therapeutics had revenue of $9.25M in the quarter ending December 31, 2025, with 223.77% growth.

• Revenue (ttm): $30.91M
• Revenue Growth: +36.75%
• P/S Ratio: 9.67
• Revenue / Employee: $291,594
• Employees: 106
• Market Cap: 284.70M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.91M	8.31M	36.75%
Dec 31, 2024	22.60M	-11.55M	-33.83%
Dec 31, 2023	34.16M	14.93M	77.63%
Dec 31, 2022	19.23M	17.91M	1,357.77%
Dec 31, 2021	1.32M	889.00K	206.74%
Dec 31, 2020	430.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-